Novus Pharmaceuticals
Novus Pharmaceuticals, a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and operates extensively across South Asia. Founded in 2013, the company has rapidly established itself as a leader in the development and distribution of high-quality generic and branded medications, focusing on therapeutic areas such as cardiology, oncology, and infectious diseases. With a commitment to innovation, Novus Pharmaceuticals offers a diverse portfolio of products that stand out for their efficacy and affordability. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. Recognised for its dedication to improving healthcare outcomes, Novus Pharmaceuticals continues to expand its reach, making a meaningful impact on the lives of patients throughout the region.
DitchCarbon Score
How does Novus Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novus Pharmaceuticals's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Novus Pharmaceuticals's reported carbon emissions
Novus Pharmaceuticals, headquartered in Bangladesh (BD), currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. While there are no stated reduction targets or climate pledges from the company, it is essential to note that many organisations in the pharmaceutical industry are increasingly focusing on sustainability and reducing their environmental impact. This trend often includes commitments to lower greenhouse gas emissions and improve energy efficiency. As Novus Pharmaceuticals continues to navigate the evolving landscape of climate responsibility, stakeholders may look forward to future disclosures that outline their emissions data and any potential commitments to sustainability initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novus Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
